HMGB1 could be a game-changer in cancer research

Recent studies showed HMGB1’s role in the fight against cancer. HMGB1 is increasingly associated with tumor stages, prognosis, immune response, and drug resistance. High Mobility Group Box 1 (HMGB1) protein has a comprehensive role in different tumors and in regulating responses to oxidative damages and cell death associated with oncogenic processes.
The growing interest in HMGB1 as a potential biomarker for cancer progression is due to its concentration changes at different stages of the disease.
This discovery enables the development of HMGB1-targeted treatments and opens a new door in cancer therapy research.
More studies are on the horizon to uncover the full potential of HMGB1.

Read the full articles about the studies:

Discover more about HMGB1 protein and request a quotation

Shopping Cart